Jeffrey Meckler
Chief Executive Officer en INDAPTUS THERAPEUTICS, INC. .
Fortuna: 743 233 $ al 31/03/2024
Cargos activos de Jeffrey Meckler
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
TRAVERE THERAPEUTICS, INC. | Director/Board Member | 18/05/2016 | - |
Independent Dir/Board Member | 18/05/2016 | - | |
Chairman | 08/06/2015 | 18/05/2016 | |
INDAPTUS THERAPEUTICS, INC. | Director/Board Member | 03/08/2021 | - |
Chief Executive Officer | 03/08/2021 | - | |
Children of Bellevue, Inc.
Children of Bellevue, Inc. Miscellaneous Commercial ServicesCommercial Services Children of Bellevue, Inc. is a non-profit organization that was founded in 1949 to improve the health and well-being of children at NYC Health + Hospitals/Bellevue. The non-profit company is based in New York, NY. The organization advocates for pediatric patients and their families and aims to alleviate the pain, loneliness, and fear that can accompany childhood hospitalization. The company also seeks to enhance early development and school-readiness in children at-risk of falling behind due to family poverty. All of their programs are made possible solely through philanthropic donations. | Director/Board Member | 01/01/2001 | - |
President | - | 01/01/2001 |
Historial de carrera de Jeffrey Meckler
Antiguos cargos conocidos de Jeffrey Meckler.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Trieber Therapeutics, Inc.
Trieber Therapeutics, Inc. BiotechnologyHealth Technology Trieber Therapeutics, Inc. is an American biotechnology company that focuses on research and development. The private company is based in Wilmington. | Chief Executive Officer | 01/01/2017 | 01/07/2017 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Director/Board Member | 04/06/2012 | 01/11/2016 |
Chief Executive Officer | 04/06/2012 | 24/10/2014 | |
Independent Dir/Board Member | 04/06/2012 | 01/11/2016 | |
COCRYSTAL PHARMA, INC. | Director/Board Member | 25/11/2014 | 22/07/2016 |
Chief Executive Officer | 01/04/2015 | 22/07/2016 | |
Clearfarma USA | Director/Board Member | 01/06/2010 | 01/11/2012 |
Cypress Bioscience, Inc.
Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Director/Board Member | 01/01/2011 | 01/09/2012 |
Chief Executive Officer | 01/01/2011 | 01/09/2012 | |
Kyalin Biosciences, Inc.
Kyalin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kyalin Biosciences, Inc. manufactures biopharmaceutical products. The firm develops an intranasal delivery form of carbetocin, which is a synthetic version of the natural occurring peptide hormone, oxytocin, for the treatment of core deficits that characterize the autistic spectrum disorders. The company was founded by Srinivas G. Rao and is headquartered in San Diego, CA. | Director/Board Member | 01/10/2011 | 01/09/2012 |
░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Formación de Jeffrey Meckler.
Fordham University School of Law | Graduate Degree |
Tepper School of Business | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 14 |
Canadá | 2 |
Israel | 2 |
Operativa
Director/Board Member | 11 |
Chief Executive Officer | 7 |
Independent Dir/Board Member | 2 |
Sectorial
Health Technology | 9 |
Commercial Services | 3 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
TRAVERE THERAPEUTICS, INC. | Health Technology |
COCRYSTAL PHARMA, INC. | Health Technology |
INDAPTUS THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 10 |
---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Cypress Bioscience, Inc.
Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Health Technology |
Alveolus, Inc.
Alveolus, Inc. Medical SpecialtiesHealth Technology Alveolus, Inc. used to develop non-vascular interventional stent technology. The company was founded by Eric K. Mangiardi and Gerard A. Silvestri in 2001 and is headquartered in Charlotte, NC. | Health Technology |
Children of Bellevue, Inc.
Children of Bellevue, Inc. Miscellaneous Commercial ServicesCommercial Services Children of Bellevue, Inc. is a non-profit organization that was founded in 1949 to improve the health and well-being of children at NYC Health + Hospitals/Bellevue. The non-profit company is based in New York, NY. The organization advocates for pediatric patients and their families and aims to alleviate the pain, loneliness, and fear that can accompany childhood hospitalization. The company also seeks to enhance early development and school-readiness in children at-risk of falling behind due to family poverty. All of their programs are made possible solely through philanthropic donations. | Commercial Services |
Andra Group, Inc. | |
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvika Joseph on October 23, 2000 and is headquartered in Jerusalem, Israel. | Health Technology |
Kyalin Biosciences, Inc.
Kyalin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kyalin Biosciences, Inc. manufactures biopharmaceutical products. The firm develops an intranasal delivery form of carbetocin, which is a synthetic version of the natural occurring peptide hormone, oxytocin, for the treatment of core deficits that characterize the autistic spectrum disorders. The company was founded by Srinivas G. Rao and is headquartered in San Diego, CA. | Health Technology |
Clearfarma USA | |
Trieber Therapeutics, Inc.
Trieber Therapeutics, Inc. BiotechnologyHealth Technology Trieber Therapeutics, Inc. is an American biotechnology company that focuses on research and development. The private company is based in Wilmington. | Health Technology |
Intec Parent, Inc. (United States) |
- Bolsa de valores
- Insiders
- Jeffrey Meckler
- Experiencia